Skip to content
10-Q

Quarterly Report

ARGOS THERAPEUTICS INC

0001171843-18-003973

← back to feed
Filed
May 15, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · May 8, 2018 10.59M sh
Operating Cash Flow Q1 2018 · Mar 31, 2018 −$5.45M
Operating Cash Flow Q1 2018 · Mar 31, 2017 −$14.38M
Long Term Debt Q1 2018 · Mar 31, 2018 $12.02M
Long Term Debt Q1 2018 · Dec 31, 2017 $12.13M
Cash And Equivalents Q1 2018 · Mar 31, 2018 $17.02M
Cash And Equivalents Q1 2018 · Dec 31, 2017 $15.19M
Cash And Equivalents Q1 2018 · Mar 31, 2017 $11.14M
Cash And Equivalents Q1 2018 · Dec 31, 2016 $52.97M
Stockholders Equity Q1 2018 · Mar 31, 2018 −$3.18M
Stockholders Equity Q1 2018 · Dec 31, 2017 −$9.23M
Current Liabilities Q1 2018 · Mar 31, 2018 $11.02M
Current Liabilities Q1 2018 · Dec 31, 2017 $9.56M
Current Assets Q1 2018 · Mar 31, 2018 $18.82M
Current Assets Q1 2018 · Dec 31, 2017 $17.18M
Total Assets Q1 2018 · Mar 31, 2018 $22.16M
Total Assets Q1 2018 · Dec 31, 2017 $20.78M
Sga Expense Q1 2018 · Mar 31, 2018 $2.5M
Sga Expense Q1 2018 · Mar 31, 2017 $3.96M
Rd Expense Q1 2018 · Mar 31, 2018 $5.55M
Rd Expense Q1 2018 · Mar 31, 2017 $7.91M
Net Income Q1 2018 · Mar 31, 2018 −$2.11M
Net Income Q1 2018 · Mar 31, 2017 −$24.08M
Operating Income Q1 2018 · Mar 31, 2018 −$2.11M
Operating Income Q1 2018 · Mar 31, 2017 −$43.98M
Capex Q1 2018 · Mar 31, 2017 $3.54M